M.E.A. Spaanderman

Kempener, B. M. J. G., Jorissen, L. M., Mulder, E. G., Ghossein-Doha, C., van Drongelen, J., Scholten, R. R., Lees, C. C., de Haas, S., Janssen, E. B. N. J., & Spaanderman, M. E. A. (2026). Hemodynamic changes in pregnancies with impaired fetal growth: A systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica, 105(2), 215-224. https://doi.org/10.1111/aogs.70102

van Doorn, D. P. C., Al-Nasiry, S., Spaanderman, M. E. A., Damoiseaux, J. G. M. C., van Paassen, P., & Timmermans, S. A. M. E. G. (2026). Thrombotic Microangiopathy During Pregnancy: Role of Soluble Fms-like Tyrosine Kinase-1-Placental Growth Factor Ratios. American Journal of Kidney Diseases, 87(2), 278-283. https://doi.org/10.1053/j.ajkd.2025.09.017

Moes, S. L., Van Lieshout, C., Kvamme, I., Schuit, E., In T Anker, E., Dirken, J., Van Eerden, L., Franx, A., Gordijn, S. J., de Heus, R., Koenen, S., Lely, A. T., Van Der Made, F., Santegoets, L., Spaanderman, M., Ahaus, K., Depmann, M., & Bekker, M. N. (2026). Cost-Effectiveness Analysis of the Multicenter Scale-Up of the SAFE@Home Telemonitoring Platform for Blood Pressure and Symptoms in Women with Hypertensive Disorders of Pregnancy. Telemedicine and E-health. Advance online publication. https://doi.org/10.1177/15305627251407897

Jansen, G., De Rooy, A., Janssen, E., Altintas, S., van 't Hof, A., Mihl, C., Kietselaer, B., Spaanderman, M., & Ghossein-Doha, C. (2026). Atherosclerosis after pre-eclampsia: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology, 67(1), 15-26. https://doi.org/10.1002/uog.70014

Hulshoff, C. C., Spaanderman, M. E. A., Scholten, R. R., & Van Drongelen, J. (2026). Predictive factors for emergency cervical cerclage efficacy in singleton and twin pregnancies: A retrospective cohort study. Acta Obstetricia et Gynecologica Scandinavica, 105(1), 105-116. https://doi.org/10.1111/aogs.70076

van der Windt, L. I., Meliezer, J. A. L., Pajkrt, E., Spaanderman, M. E. A., Scheepers, H. C. J., Mol, B. W., Oudijk, M. A., Ravelli, A. C. J., & Roos, C. (2026). School Performance After Maintenance Tocolysis With Nifedipine for Threatened Preterm Birth: 12-Year Follow-Up of the APOSTEL 2 Trial. Bjog-an International Journal of Obstetrics and Gynaecology, 133(2), 334-344. https://doi.org/10.1111/1471-0528.70030

Hamers, M., Janssen, E. B. N. J., Bottema, I., Villamor, E., Van Mechelen, K., & Spaanderman, M. E. A. (2025). Reference ranges of blood glucose values in healthy term neonates in their first days of life: a systematic review and meta-analysis. European Journal of Pediatrics, 185(1), Article 19. https://doi.org/10.1007/s00431-025-06618-3

Moes, S. L., Depmann, M., Kvamme, I., Schuit, E., Anker, E. I. ., Dirken, J., Van Eerden, L., Franx, A., Gordijn, S., De Heus, R., Koenen, S., Van Der Made, F., Santegoets, L., Spaanderman, M., Lely, A. T., & Bekker, M. N. (2025). Safety and impact of self-monitoring blood pressure through a digital platform in high-risk pregnancies in 11 hospitals: The multicenter before-after SAFE@home II study. Pregnancy Hypertension, 42, Article 101268. https://doi.org/10.1016/j.preghy.2025.101268

Orabona, R., Sciatti, E., Prefumo, F., Spaanderman, M. E. A., Senni, M., de Boer, R. A., & Ghossein-Doha, C. (2025). Sodium-Glucose Cotransporter 2 Inhibitors After Preeclampsia: A Therapeutic Promise? JACC: Heart Failure, 13(11), Article 102688. https://doi.org/10.1016/j.jchf.2025.102688

Stampalija, T., Lees, C., Ghi, T., Cornette, J., Gyselaers, W., Ferrazzi, E., Mousa, T., Spaanderman, M., Thilaganathan, B., Valensise, H., & Collaborators (2025). ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction. Ultrasound in Obstetrics & Gynecology, 66(5), 681-696. https://doi.org/10.1002/uog.70040